Can I Take Mounjaro If I Have Gallstones?

GLP-1 medicines including tirzepatide can slow gallbladder emptying, which may raise the risk of new or worsening gallbladder problems.
Having gallstones does not automatically rule out Mounjaro, but the full picture — symptom history, previous surgery, current medication — must be reviewed by a prescriber.
Urgent symptoms to know: severe pain in the upper right abdomen, pain spreading to the shoulder or back, fever, or yellowing of the skin. Seek medical help straight away for any of these.
Weight loss itself, regardless of how it is achieved, can trigger gallstone formation or cause existing stones to become symptomatic, a fact the prescriber will factor in.

Taking Mounjaro with gallstones requires careful clinical assessment. GLP-1 and GIP receptor agonists like tirzepatide are known to increase the risk of gallbladder problems, including gallstones, so anyone who already has them needs a prescriber to weigh up that history before treatment begins. Mounjaro is a prescription-only medicine; a clinician decides whether it is suitable for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says, and how a prescriber thinks through this decision

Why gallbladder health matters specifically with tirzepatide

Tirzepatide acts on two gut-hormone receptors, GIP and GLP-1. One well-documented effect of GLP-1 receptor activation is that it slows the rate at which the gallbladder contracts and empties bile. When bile sits for longer, the conditions for crystal formation improve, which is part of why gallbladder problems showed up as a recognised side effect across the SURMOUNT clinical trial programme.

The NHS patient information for tirzepatide lists gallbladder problems as a side effect that requires medical attention, and the medicine's Summary Care Record prompts prescribers to consider gallbladder history at assessment. That does not mean Mounjaro is off the table for everyone with a history of gallstones, it means the risk has to be honestly factored into the decision, not skipped over.

Rapid weight loss also independently encourages gallstone formation. When body fat breaks down quickly, the liver excretes more cholesterol into bile, which can supersaturate it. So the clinical picture here has two moving parts: the pharmacological effect of the medicine itself, and the metabolic consequence of losing weight effectively. A good prescriber will discuss both with you, not just tick the eligibility boxes.

The decision a prescriber actually makes, and what tips it either way

If you are wondering whether you can take Mounjaro with gallstones, the honest answer is: it depends on several factors, and those factors need a clinical conversation rather than a general rule. The things a prescriber will want to understand include whether your gallstones are currently causing symptoms, whether you have had a cholecystectomy (gallbladder removal), whether you have had episodes of acute cholecystitis or biliary colic, and what other medicines you take.

Someone who had their gallbladder removed years ago and has no ongoing biliary symptoms is in a very different position from someone currently managing active gallstone disease. For the former, the gallbladder risk is largely resolved. For the latter, a prescriber may conclude that starting a medicine that further slows gallbladder emptying is not the right step at this point, or may want a specialist opinion first.

You can read more about the range of conditions that affect Mounjaro eligibility on our overview of who can take Mounjaro. Similarly, if kidney disease is part of your health picture alongside gallstones, the Mounjaro and CKD page covers how that assessment works. Each variable is reviewed on its own terms, then as part of the whole.

What a prescriber is never doing is rubber-stamping a request. At nume, every consultation is personally read by a GPhC-registered Independent Prescriber (not software) on the same day it is submitted. The gallstone question is exactly the kind of nuanced history that makes that human review matter.

Signs that need urgent attention during treatment

Whether or not you have a pre-existing gallbladder history, knowing what to watch for during treatment is genuinely useful. The symptoms that should prompt you to stop taking Mounjaro and seek medical help promptly are: sudden, severe pain in the upper right side of your abdomen; pain that moves into your right shoulder or between your shoulder blades; a high temperature or shivering; nausea and vomiting alongside that pain; or yellowing of the skin or whites of the eyes (jaundice).

These overlap with the symptoms of acute cholecystitis, choledocholithiasis (a stone in the bile duct), or pancreatitis, all of which can be serious if left untreated. The MHRA Yellow Card scheme exists so patients can report suspected side effects from any medicine, including new or worsening gallbladder symptoms on tirzepatide; it is worth knowing about even if you never need it.

If you already take medication for a digestive condition alongside your gallstone history, it is worth reading about how common medicines interact with Mounjaro so you go into your consultation fully informed. A prescriber can only work with what you tell them, so the more complete your history, the better the assessment.

Your next step

Mounjaro is a prescription-only medicine, which means the eligibility decision always sits with a prescriber rather than a website. If your BMI meets the threshold for consideration, our guide to BMI eligibility for Mounjaro explains where the numbers stand; if you are near the lower boundary, the BMI 27 eligibility page addresses that scenario specifically.

The cost of treatment is a practical consideration too, and the background to Mounjaro pricing in the UK gives honest context on how prices are structured. Most people find they have more questions once they start reading, which is exactly what our consultation is for. You can submit yours any time before 12pm on a weekday and it will be reviewed the same day.

If you are ready to talk through your gallstone history and whether Mounjaro is a realistic option for you, the right place to start is a free, no-obligation consultation. Speak to our prescribers and get a personalised clinical view rather than a general answer.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions